$RMNI
Rimini Street, Inc.

2017 Q1 Form 10-Q Financial Statement

#000114420417026205 Filed on May 11, 2017

View on sec.gov

Income Statement

Concept 2017 Q1
Revenue $49.07M
YoY Change 41.5%
Cost Of Revenue $18.36M
YoY Change 25.98%
Gross Profit $30.71M
YoY Change 52.75%
Gross Profit Margin 62.59%
Selling, General & Admin $23.97M
YoY Change 8.11%
% of Gross Profit 78.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $476.0K
YoY Change
% of Gross Profit 1.55%
Operating Expenses $27.92M
YoY Change 25.9%
Operating Profit $2.797M
YoY Change -137.57%
Interest Expense $9.936M
YoY Change 4609.0%
% of Operating Profit 355.24%
Other Income/Expense, Net $89.00K
YoY Change -220.27%
Pretax Income -$14.03M
YoY Change 81.55%
Income Tax $441.0K
% Of Pretax Income
Net Earnings -$14.48M
YoY Change 81.01%
Net Earnings / Revenue -29.5%
Basic Earnings Per Share -$0.59
Diluted Earnings Per Share -$0.59
COMMON SHARES
Basic Shares Outstanding 24.35M shares
Diluted Shares Outstanding 24.35M shares

Balance Sheet

Concept 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change -100.0%
Cash & Equivalents $33.35M
Short-Term Investments
Other Short-Term Assets $300.0K
YoY Change 200.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $300.0K
YoY Change -70.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $173.2M
YoY Change 0.23%
Total Long-Term Assets $173.2M
YoY Change 0.23%
TOTAL ASSETS
Total Short-Term Assets $300.0K
Total Long-Term Assets $173.2M
Total Assets $173.5M
YoY Change -0.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.0K
YoY Change -90.91%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $133.9K
YoY Change -98.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $8.700M
YoY Change
Total Long-Term Liabilities $8.700M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $133.9K
Total Long-Term Liabilities $8.700M
Total Liabilities $8.900M
YoY Change 25.35%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $164.6M
YoY Change
Total Liabilities & Shareholders Equity $173.5M
YoY Change -0.17%

Cashflow Statement

Concept 2017 Q1
OPERATING ACTIVITIES
Net Income -$14.48M
YoY Change 81.01%
Depreciation, Depletion And Amortization $476.0K
YoY Change
Cash From Operating Activities $6.594M
YoY Change -6694.0%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$100.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$1.650M
YoY Change
NET CHANGE
Cash From Operating Activities $6.594M
Cash From Investing Activities -100.0K
Cash From Financing Activities -$1.650M
Net Change In Cash $4.944M
YoY Change -5044.0%
FREE CASH FLOW
Cash From Operating Activities $6.594M
Capital Expenditures -$100.0K
Free Cash Flow $6.694M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2016Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
635681 USD
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
133932 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
698690 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-179386 USD
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
200175 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-4271 USD
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2017Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
179386 USD
CY2016Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1066912 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1066912 USD
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2017Q1 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
-25060 USD
CY2016Q1 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
103291 USD
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5320250 shares
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5649918 shares
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
70923 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
38749 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-147212 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
147212 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
CY2017Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
147212 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
0 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-95529 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
967449 USD
CY2016Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2017Q1 gpiau Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
-4271 USD
CY2016Q1 gpiau Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
-802394 USD
CY2017Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2015-01-28
CY2015Q2 gpiau Common Units Issued In Initial Public Offering
CommonUnitsIssuedInInitialPublicOffering
17250000 shares
CY2015Q2 us-gaap Other Ownership Interests Offering Costs
OtherOwnershipInterestsOfferingCosts
10960590 USD
CY2015Q2 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
4312500 USD
CY2015Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
6037500 USD
CY2015Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
172500000 USD
CY2017Q1 gpiau Reduction Of Intangible Assets Due To Redemption
ReductionOfIntangibleAssetsDueToRedemption
5000001 USD
CY2017Q1 gpiau Interest On Dissolution Expenses
InterestOnDissolutionExpenses
100000 USD
CY2017Q1 us-gaap Interest Income Other
InterestIncomeOther
727000 USD
CY2017Q1 gpiau Cash Held Outside Of Trust Account
CashHeldOutsideOfTrustAccount
1551 USD
CY2017Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
3400000 USD
CY2017Q1 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
173227105 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
14687500 shares
CY2016Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
161227 USD
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1047005 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
75622 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-95529 USD
CY2017Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2015Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
562500 shares
CY2015Q2 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
10000 USD
CY2017Q1 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
90000 USD
CY2017Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 USD
CY2016Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 USD
CY2016Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
60000 USD
CY2016Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
635681 USD
CY2017Q1 gpiau Working Capital Loan
WorkingCapitalLoan
1000000 USD
CY2017Q1 gpiau Contingent Transaction Fee Amount
ContingentTransactionFeeAmount
3993000 USD
CY2015Q2 gpiau Underwriters Discount Percentage
UnderwritersDiscountPercentage
0.060 pure
CY2015Q2 gpiau Payments To Underwriters In Cash
PaymentsToUnderwritersInCash
4312500 USD
CY2015Q2 gpiau Underwriters Deferred Discount Amount
UnderwritersDeferredDiscountAmount
6037500 USD
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
GP Investments Acquisition Corp.
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001635282
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2017Q1 dei Trading Symbol
TradingSymbol
GPIAU
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21562500 shares
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
15896071 shares
CY2016Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
15912582 shares
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5666429 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5649918 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5649918 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5666429 shares
CY2017Q1 gpiau Stock Redemption Restricted Percentage
StockRedemptionRestrictedPercentage
0.2 pure
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><i>Use of estimates</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><i>Concentration of credit risk</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0in 0in 0pt" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times may exceed the Federal depository insurance coverage of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>. At March 31, 2017, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q1 gpiau Reclassification Of Related Party Advances To Related Party Promissory Notes
ReclassificationOfRelatedPartyAdvancesToRelatedPartyPromissoryNotes
635681 USD
CY2016Q1 gpiau Reclassification Of Related Party Advances To Related Party Promissory Notes
ReclassificationOfRelatedPartyAdvancesToRelatedPartyPromissoryNotes
0 USD
CY2017Q1 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
3400000 USD

Files In Submission

Name View Source Status
0001144204-17-026205-index-headers.html Edgar Link pending
0001144204-17-026205-index.html Edgar Link pending
0001144204-17-026205.txt Edgar Link pending
0001144204-17-026205-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gpiau-20170331.xml Edgar Link completed
gpiau-20170331.xsd Edgar Link pending
gpiau-20170331_cal.xml Edgar Link unprocessable
gpiau-20170331_def.xml Edgar Link unprocessable
gpiau-20170331_lab.xml Edgar Link unprocessable
gpiau-20170331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v465963_10q.htm Edgar Link pending
v465963_ex31.htm Edgar Link pending
v465963_ex32.htm Edgar Link pending